New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II

被引:61
作者
Biagi, G
Giorgi, I
Livi, O
Scartoni, V
Betti, L
Giannacini, G
Trincavelli, ML
机构
[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy
[2] Univ Pisa, Dipartimento Psiciat Neurobiol Farmacol & Biotecn, I-56126 Pisa, Italy
关键词
1,2,3-triazolo[1,5-a]quinoxalines; benzodiazepine receptor binding; adenosine receptor binding;
D O I
10.1016/S0223-5234(02)01376-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On pursuing research about 1,2,3-triazolo[1,5-a]quinoxalines. in this paper we report synthesis and binding assays toward the benzodiazepine and A(1) and A(2A) adenosine receptors. of a new series of derivatives, bearing some structural changes (introduction of fluorine and trifluoromethyl in the seventh position, amino substituents in the fourth position, benzyl group in the fifth position and aroyl substituents in the third position). The biological tests have shown that only the 7-fluorosubstituted compounds 3a and 4a and the N-benzyl derivative 7 have a good affinity toward the benzodiazepine receptors, while only the 7-trifluoromethyl substituted compound 3b presents a moderate affinity with low selectivity toward the A, adenosine receptors. The other structural modifications strongly decreased biological activity. (C) 2002 Published by Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 10 条
[1]  
Baraldi PG, 1995, CURR MED CHEM, V2, P707
[2]   1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors [J].
Bertelli, L ;
Biagi, G ;
Giorgi, I ;
Manera, C ;
Livi, O ;
Scartoni, V ;
Betti, L ;
Giannaccini, G ;
Trincavelli, L ;
Barili, PL .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (02) :113-122
[3]   Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyramidines with high affinity toward A1 adenosine receptors [J].
Betti, L ;
Biagi, G ;
Giannaccini, G ;
Giorgi, I ;
Livi, O ;
Lucacchini, A ;
Manera, C ;
Scartoni, V .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (05) :668-673
[4]  
BEYE C, 1887, BER, V20, P2078
[5]  
Biagi G, 1996, FARMACO, V51, P131
[6]  
Biagi G, 1996, FARMACO, V51, P601
[8]   POTENTIAL ANTILEUKEMIC AND IMMUNOSUPPRESSIVE DRUGS .3. EFFECTS OF HOMOCYCLIC RING SUBSTITUTION ON IN-VITRO DRUG ACTIVITY OF 4-NITROBENZO-2,1,3-OXADIAZOLES (4-NITROBENZOFURAZANS) AND THEIR N-OXIDES (4-NITROBENZOFUROXANS) [J].
GHOSH, PB ;
WHITEHOUSE, MW ;
TERNAI, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (03) :255-+
[9]  
Musante C., 1958, GAZZ CHIM ITAL, V88, P879
[10]  
SMITH PAS, 1951, ORG SYNTH, V31, P14